Cervical cancer patients with E545K or E542K mutant tumors have inferior survival outcomes after standard chemoradiation (cisplatin plus pelvic RT).

Kaplan-Meier survival probability comparing tumors with high Pol η expression to those with low Pol η expression.

Wendi Zhou (500394)
Yih-wen Chen (500395)
Xiyong Liu (438656)
Peiguo Chu (341121)
Sofia Loria (500396)
Yafan Wang (500397)
Yun Yen (51800)
Kai-Ming Chou (500398)

December 2013

The blue curve corresponds to patients with high Pol η level and the red curve to patients with l...

Univariate and multivariate analyses for the correlation of clinicopathologic variables and CHI3L1 risk haplotype expressions with overall survival of the patients with uterine cervical cancer.

Yue-Shan Lin (627588)
Yu-Fan Liu (216072)
Ying-Erh Chou (546746)
Shun-Fa Yang (155103)
Ming-Hsien Chien (155089)
Chih-Hsien Wu (627589)
Chi-Hung Chou (538311)
Chao-Wen Cheng (84263)
Po-Hui Wang (538314)

September 2014

Statistical analysis: Kaplan-Meier model and multivariate and univariate Cox regression models.</...

MAP17 and SGLT1 levels and the combination are good independent markers for survival.

Marco Perez (281760)
Juan M. Praena-Fernandez (281761)
Blanca Felipe-Abrio (281762)
Maria A. Lopez-Garcia (281763)
Antonio Lucena-Cacace (281764)
Angel Garcia (90471)
Matilde Lleonart (281765)
Guiovanna Roncador (281766)
Juan J. Marin (281767)
Amancio Carnero (43507)

February 2013

A) A Kaplan-Meier curve is shown indicating that MAP17 could be a good prognostic marker for surv...

Kaplan-Meier survival curves showing overall survival according to PIK3CA mutation status (wild-type versus mutated) in (A) all colorectal carcinoma patients and (B) only in patients with BRAF wild-type tumor.

Christophe Rosty (245644)
Joanne P. Young (163036)
Michael D. Walsh (245558)
Mark Clendenning (245560)
Kristy Sanderson (421771)
Rhiannon J. Walters (245562)
Susan Parry (163034)
Mark A. Jenkins (108168)
Aung Ko Win (245555)
Melissa C. Southey (89921)
John L. Hopper (89919)
Graham G. Giles (89916)
Elizabeth J. Williamson (421772)
Dallas R. English (89920)
Daniel D. Buchanan (245549)

June 2013

Kaplan-Meier survival curves showing overall survival according to PIK3CA mutation status ...

The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.

Shan Wang (120085)
Yuan Wang (14955)
Jiaru Zhuang (17014835)
Yibo Wu (788885)
Weifeng Shi (126753)
Lei Wang (6656)

September 2023

The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.</p

Kaplan-Meier survival curves for cervical cancer patients according to disease stage.

Saul Rassy Carneiro (4597846)
Marcela de Araújo Fagundes (4597843)
Pricila de Jesus Oliveira do Rosário (4597837)
Laura Maria Tomazi. Neves (4597840)
Givago da Silva Souza (513286)
Maria da Conceição Nascimento Pinheiro (836673)

November 2017

Belém, Pará, Brazil. 2005–2010. Group 1: stages IA to IB. Group 2: stages IIA to IV B.</p

Kaplan-Meier survival curves comparing cumulative survival at teaching facilities (TF) and non-teaching facilities (NTF) for (a) cervical cancer, (b) ovarian cancer, (c) endometrial cancer, (d) uterine sarcoma, and (e) vulvar cancer and at high-volume centers (HVC), intermediate-volume centers (IVC), and low-volume centers (LVC) for (f) cervical cancer, (g) ovarian cancer, (h) endometrial cancer, (i) uterine sarcoma, and (j) vulvar cancer.

Kathleen F. Brookfield (375175)
Michael C. Cheung (375177)
Relin Yang (375178)
Margaret M. Byrne (375181)
Leonidas G. Koniaris (213282)

February 2013

Kaplan-Meier survival curves comparing cumulative survival at teaching facilities (TF) and non-te...

Five-year disease-free survival by mutational status per histological subtype.

Vivian M. Spaans (543225)
Marjolijn D. Trietsch (543226)
Alexander A. W. Peters (760945)
Michelle Osse (773403)
Natalja ter Haar (773404)
Gert J. Fleuren (773405)
Ekaterina S. Jordanova (160493)

July 2015

Five-year disease-free Kaplan-Meier survival curves for cervical squamous cell carcinoma (A), cer...

The Kaplan–Meier curves for overall survival of cervical cancer patients based on LANR.

Shan Wang (120085)
Yuan Wang (14955)
Jiaru Zhuang (17014835)
Yibo Wu (788885)
Weifeng Shi (126753)
Lei Wang (6656)

September 2023

The Kaplan–Meier curves for overall survival of cervical cancer patients based on LANR.</p

Survival analysis of women with cervical cancer according to FIGO staging and CDKN3 expression.

Ana María Espinosa (280116)
Ana Alfaro (280118)
Edgar Roman-Basaure (180147)
Mariano Guardado-Estrada (180155)
Ícela Palma (280120)
Cyntia Serralde (280123)
Ingrid Medina (280125)
Eligia Juárez (280127)
Miriam Bermúdez (280129)
Edna Márquez (280130)
Manuel Borges-Ibáñez (280131)
Sergio Muñoz-Cortez (280132)
Avissai Alcántara-Vázquez (280133)
Patricia Alonso (280134)
José Curiel-Valdez (280135)
Susana Kofman (180158)
Nicolas Villegas (280136)
Jaime Berumen (180161)

February 2013

The Kaplan-Meier curves for FIGO staging and CDKN3 are shown. Patients were followed-up fo...

Kaplan-Meier curves for overall survival in ESCC.

Lin Wang (11986)
Ling Shan (155985)
Shaokai Zhang (603032)
Jianming Ying (155982)
Liyan Xue (149161)
Yanling Yuan (603033)
Yongqiang Xie (603034)
Ning Lu (22589)

July 2014

(A) Overall survival according to PIK3CA mutation status (P = 0.251). (B) Overall survival accord...

Survival analysis of women with cervical cancer according to CDKN3 expression.

Eira Valeria Barrón (796117)
Edgar Roman-Bassaure (570297)
Ana Laura Sánchez-Sandoval (796118)
Ana María Espinosa (280116)
Mariano Guardado-Estrada (180155)
Ingrid Medina (280125)
Eligia Juárez (280127)
Ana Alfaro (280118)
Miriam Bermúdez (280129)
Rubén Zamora (5665222)
Carlos García-Ruiz (796119)
Juan Carlos Gomora (796120)
Susana Kofman (180158)
E. Martha Pérez-Armendariz (796121)
Jaime Berumen (180161)

September 2015

The Kaplan-Meier curves for cyclin-dependent kinase inhibitor 3 (CDKN3) expression are shown. Pat...

Kaplan-Meier curve for overall survival in patients with mutant EGFR mutation versus those with wild type EGFR after the diagnosis of brain metastasis.

Wei-Yuan Chang (4856686)
Yi-Lin Wu (264289)
Po-Lan Su (4856683)
Szu-Chun Yang (4856689)
Chien-Chung Lin (244489)
Wu-Chou Su (216249)

February 2018

Kaplan-Meier curve for overall survival in patients with mutant EGFR mutation versus those with w...

Kaplan-Meier curves for cancer-specific survival of stage II and T2 with PSA≥20ng/ml.

Wen-jun Xiao (4582369)
Yao Zhu (441601)
Bo Dai (448609)
Ding-wei Ye (4582372)

November 2017

Kaplan-Meier curves for cancer-specific survival of stage II and T2 with PSA≥20ng/ml.</p

Kaplan-Meier curves for cancer-specific survival of stage II, stage IIIB and T2 with grade group 5 and PSA≥20ng/ml.

Wen-jun Xiao (4582369)
Yao Zhu (441601)
Bo Dai (448609)
Ding-wei Ye (4582372)

November 2017

Kaplan-Meier curves for cancer-specific survival of stage II, stage IIIB and T2 with grade group ...

Kaplan-Meier survival probability comparing tumors with high Pol η expression to those with low Pol η expression.

Wendi Zhou (500394)
Yih-wen Chen (500395)
Xiyong Liu (438656)
Peiguo Chu (341121)
Sofia Loria (500396)
Yafan Wang (500397)
Yun Yen (51800)
Kai-Ming Chou (500398)

December 2013

The blue curve corresponds to patients with high Pol η level and the red curve to patients with l...

Univariate and multivariate analyses for the correlation of clinicopathologic variables and CHI3L1 risk haplotype expressions with overall survival of the patients with uterine cervical cancer.

Yue-Shan Lin (627588)
Yu-Fan Liu (216072)
Ying-Erh Chou (546746)
Shun-Fa Yang (155103)
Ming-Hsien Chien (155089)
Chih-Hsien Wu (627589)
Chi-Hung Chou (538311)
Chao-Wen Cheng (84263)
Po-Hui Wang (538314)

September 2014

Statistical analysis: Kaplan-Meier model and multivariate and univariate Cox regression models.</...

MAP17 and SGLT1 levels and the combination are good independent markers for survival.

Marco Perez (281760)
Juan M. Praena-Fernandez (281761)
Blanca Felipe-Abrio (281762)
Maria A. Lopez-Garcia (281763)
Antonio Lucena-Cacace (281764)
Angel Garcia (90471)
Matilde Lleonart (281765)
Guiovanna Roncador (281766)
Juan J. Marin (281767)
Amancio Carnero (43507)

February 2013

A) A Kaplan-Meier curve is shown indicating that MAP17 could be a good prognostic marker for surv...

Kaplan-Meier survival curves showing overall survival according to PIK3CA mutation status (wild-type versus mutated) in (A) all colorectal carcinoma patients and (B) only in patients with BRAF wild-type tumor.

Christophe Rosty (245644)
Joanne P. Young (163036)
Michael D. Walsh (245558)
Mark Clendenning (245560)
Kristy Sanderson (421771)
Rhiannon J. Walters (245562)
Susan Parry (163034)
Mark A. Jenkins (108168)
Aung Ko Win (245555)
Melissa C. Southey (89921)
John L. Hopper (89919)
Graham G. Giles (89916)
Elizabeth J. Williamson (421772)
Dallas R. English (89920)
Daniel D. Buchanan (245549)

June 2013

Kaplan-Meier survival curves showing overall survival according to PIK3CA mutation status ...

The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.

Shan Wang (120085)
Yuan Wang (14955)
Jiaru Zhuang (17014835)
Yibo Wu (788885)
Weifeng Shi (126753)
Lei Wang (6656)

September 2023

The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.</p

Kaplan-Meier survival curves for cervical cancer patients according to disease stage.

Saul Rassy Carneiro (4597846)
Marcela de Araújo Fagundes (4597843)
Pricila de Jesus Oliveira do Rosário (4597837)
Laura Maria Tomazi. Neves (4597840)
Givago da Silva Souza (513286)
Maria da Conceição Nascimento Pinheiro (836673)

November 2017

Belém, Pará, Brazil. 2005–2010. Group 1: stages IA to IB. Group 2: stages IIA to IV B.</p

Kaplan-Meier survival curves comparing cumulative survival at teaching facilities (TF) and non-teaching facilities (NTF) for (a) cervical cancer, (b) ovarian cancer, (c) endometrial cancer, (d) uterine sarcoma, and (e) vulvar cancer and at high-volume centers (HVC), intermediate-volume centers (IVC), and low-volume centers (LVC) for (f) cervical cancer, (g) ovarian cancer, (h) endometrial cancer, (i) uterine sarcoma, and (j) vulvar cancer.

Kathleen F. Brookfield (375175)
Michael C. Cheung (375177)
Relin Yang (375178)
Margaret M. Byrne (375181)
Leonidas G. Koniaris (213282)

February 2013

Kaplan-Meier survival curves comparing cumulative survival at teaching facilities (TF) and non-te...

Five-year disease-free survival by mutational status per histological subtype.

Vivian M. Spaans (543225)
Marjolijn D. Trietsch (543226)
Alexander A. W. Peters (760945)
Michelle Osse (773403)
Natalja ter Haar (773404)
Gert J. Fleuren (773405)
Ekaterina S. Jordanova (160493)

July 2015

Five-year disease-free Kaplan-Meier survival curves for cervical squamous cell carcinoma (A), cer...

The Kaplan–Meier curves for overall survival of cervical cancer patients based on LANR.

Shan Wang (120085)
Yuan Wang (14955)
Jiaru Zhuang (17014835)
Yibo Wu (788885)
Weifeng Shi (126753)
Lei Wang (6656)

September 2023

The Kaplan–Meier curves for overall survival of cervical cancer patients based on LANR.</p

Survival analysis of women with cervical cancer according to FIGO staging and CDKN3 expression.

Ana María Espinosa (280116)
Ana Alfaro (280118)
Edgar Roman-Basaure (180147)
Mariano Guardado-Estrada (180155)
Ícela Palma (280120)
Cyntia Serralde (280123)
Ingrid Medina (280125)
Eligia Juárez (280127)
Miriam Bermúdez (280129)
Edna Márquez (280130)
Manuel Borges-Ibáñez (280131)
Sergio Muñoz-Cortez (280132)
Avissai Alcántara-Vázquez (280133)
Patricia Alonso (280134)
José Curiel-Valdez (280135)
Susana Kofman (180158)
Nicolas Villegas (280136)
Jaime Berumen (180161)

February 2013

The Kaplan-Meier curves for FIGO staging and CDKN3 are shown. Patients were followed-up fo...

Kaplan-Meier curves for overall survival in ESCC.

Lin Wang (11986)
Ling Shan (155985)
Shaokai Zhang (603032)
Jianming Ying (155982)
Liyan Xue (149161)
Yanling Yuan (603033)
Yongqiang Xie (603034)
Ning Lu (22589)

July 2014

(A) Overall survival according to PIK3CA mutation status (P = 0.251). (B) Overall survival accord...

Survival analysis of women with cervical cancer according to CDKN3 expression.

Eira Valeria Barrón (796117)
Edgar Roman-Bassaure (570297)
Ana Laura Sánchez-Sandoval (796118)
Ana María Espinosa (280116)
Mariano Guardado-Estrada (180155)
Ingrid Medina (280125)
Eligia Juárez (280127)
Ana Alfaro (280118)
Miriam Bermúdez (280129)
Rubén Zamora (5665222)
Carlos García-Ruiz (796119)
Juan Carlos Gomora (796120)
Susana Kofman (180158)
E. Martha Pérez-Armendariz (796121)
Jaime Berumen (180161)

September 2015

The Kaplan-Meier curves for cyclin-dependent kinase inhibitor 3 (CDKN3) expression are shown. Pat...

Kaplan-Meier curve for overall survival in patients with mutant EGFR mutation versus those with wild type EGFR after the diagnosis of brain metastasis.

Wei-Yuan Chang (4856686)
Yi-Lin Wu (264289)
Po-Lan Su (4856683)
Szu-Chun Yang (4856689)
Chien-Chung Lin (244489)
Wu-Chou Su (216249)

February 2018

Kaplan-Meier curve for overall survival in patients with mutant EGFR mutation versus those with w...

Kaplan-Meier curves for cancer-specific survival of stage II and T2 with PSA≥20ng/ml.

Wen-jun Xiao (4582369)
Yao Zhu (441601)
Bo Dai (448609)
Ding-wei Ye (4582372)

November 2017

Kaplan-Meier curves for cancer-specific survival of stage II and T2 with PSA≥20ng/ml.</p

Kaplan-Meier curves for cancer-specific survival of stage II, stage IIIB and T2 with grade group 5 and PSA≥20ng/ml.

Wen-jun Xiao (4582369)
Yao Zhu (441601)
Bo Dai (448609)
Ding-wei Ye (4582372)

November 2017

Kaplan-Meier curves for cancer-specific survival of stage II, stage IIIB and T2 with grade group ...

Kaplan-Meier survival probability comparing tumors with high Pol η expression to those with low Pol η expression.

Wendi Zhou (500394)
Yih-wen Chen (500395)
Xiyong Liu (438656)
Peiguo Chu (341121)
Sofia Loria (500396)
Yafan Wang (500397)
Yun Yen (51800)
Kai-Ming Chou (500398)

December 2013

The blue curve corresponds to patients with high Pol η level and the red curve to patients with l...

Univariate and multivariate analyses for the correlation of clinicopathologic variables and CHI3L1 risk haplotype expressions with overall survival of the patients with uterine cervical cancer.

Yue-Shan Lin (627588)
Yu-Fan Liu (216072)
Ying-Erh Chou (546746)
Shun-Fa Yang (155103)
Ming-Hsien Chien (155089)
Chih-Hsien Wu (627589)
Chi-Hung Chou (538311)
Chao-Wen Cheng (84263)
Po-Hui Wang (538314)

September 2014

Statistical analysis: Kaplan-Meier model and multivariate and univariate Cox regression models.</...

MAP17 and SGLT1 levels and the combination are good independent markers for survival.

Marco Perez (281760)
Juan M. Praena-Fernandez (281761)
Blanca Felipe-Abrio (281762)
Maria A. Lopez-Garcia (281763)
Antonio Lucena-Cacace (281764)
Angel Garcia (90471)
Matilde Lleonart (281765)
Guiovanna Roncador (281766)
Juan J. Marin (281767)
Amancio Carnero (43507)

February 2013

A) A Kaplan-Meier curve is shown indicating that MAP17 could be a good prognostic marker for surv...

Cervical cancer patients with E545K or E542K mutant tumors have inferior survival outcomes after standard chemoradiation (cisplatin plus pelvic RT).

Abstract

Extracted data

Cervical cancer patients with E545K or E542K mutant tumors have inferior survival outcomes after standard chemoradiation (cisplatin plus pelvic RT).

Abstract

Extracted data

Related items

Related items